¥ê¥ó¥¯½¸
¥á¥¤¥ó | ÅÐÏ¿¤¹¤ë | ¿Íµ¤¥µ¥¤¥È (top10) | ¹âɾ²Á¥µ¥¤¥È (top10) | ¤ª¤¹¤¹¤á¥µ¥¤¥È (7) | Áê¸ß¥ê¥ó¥¯¥µ¥¤¥È (1) |
¥«¥Æ¥´¥ê°ìÍ÷ | RSS/ATOM Âбþ¥µ¥¤¥È (18) | RSS/ATOM µ»ö (66486) | ¥é¥ó¥À¥à¥¸¥ã¥ó¥× |
RSS/ATOM µ»ö (66486)
¤³¤³¤Ëɽ¼¨¤µ¤ì¤Æ¤¤¤ë RSS/ATOM µ»ö¤ò RSS ¤È ATOM ¤ÇÇÛ¿®¤·¤Æ¤¤¤Þ¤¹¡£


Novartis¼Ò¡¢ÆüËܤǤÎÁá´üÎ×¾²»î¸³³ÈÂç¤Ë¸þ¤±ÆüËܤ˥ȥé¥ó¥¹¥ì¡¼¥·¥ç¥Ê¥ëÁÈ¿¥¿·Àß from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2025-3-18 7:00) |
¡¡¥¹¥¤¥¹Novartis¡Ê¥Î¥Ð¥ë¥Æ¥£¥¹¡Ë¼Ò¤ÎÆüËÜË¡¿Í¤Î¥Î¥Ð¥ë¥Æ¥£¥¹¥Õ¥¡¡¼¥Þ¤Ï¡¢ÆüËܤˤª¤±¤ë¥Õ¥¡¡¼¥¹¥È¥¤¥ó¥Ò¥å¡¼¥Þ¥ó¡ÊFIH»î¸³¡Ë¤äÁá´üÎ×¾²»î¸³¤ò³ÈÂ礵¤»¤ë¡£2025ǯ3·î17Æü¡¢ÆüËÜË¡¿Í¤ÎÃæ¤Ë¡¢¿·¤¿¤Ë¡Ö¥¯¥ê¥Ë¥«¥ë¥È¥é¥ó¥¹¥ì¡¼¥·¥ç¥Ê¥ë¥ê¥µ¡¼¥Á¥Ï¥Ö¡ÊClinical Translational Research Hub¡Ë¡×¤òÀßÃÖ¤·¡¢Ìó50¿Í¤òÁý°÷¤·¤ÆÆüËܤǤθ¦µæ³«È¯¤ò¶¯²½¤¹¤ë¤Èȯɽ¤·¤¿¡£
|
¹¾ºê¥°¥ê¥³¡¢¥Ò¥È¤ÎÌȱ֤òÉê³è²½¤µ¤»É÷¼Ù¤Î¼«³Ð¾É¾õ¤òÄ㸺¤¹¤ëÆý»À¶Ý³ô¤òȯ¸« from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2025-3-18 7:00) |
¡¡¹¾ºê¥°¥ê¥³¤Ï2025ǯ3·î17Æü¡¢¥Ò¥È¤ÎÂΤÎÌȱ֤òÉê³è²½¤µ¤»¤ëÆý»À¶Ý³ô¡ÖLactobacillus helveticus GCL1815³ô¡×¡Ê°Ê²¼GCL1815³ô¡Ë¤òȯ¸«¤·¤¿¤Èȯɽ¤·¤¿¡£Æ±¼Ò¤¬ÊÝͤ¹¤ëÆý»À¶Ý¥é¥¤¥Ö¥é¥ê¡¼¤«¤éõº÷¤·¤¿¡£in vitro¤Ç¤ÎÌȱÖÉê³è²½ºîÍѤ˲䨡¢Î×¾²¸¦µæ¤ÇÉ÷¼Ù¤Î¼«³Ð¾É¾õ¤òÄ㸺¤¹¤ë¤³¤È¤â³Î¤«¤á¤é¤ì¤¿¤È¤¤¤¦¡£
|
Eli Lilly¼Ò¡¢ÊƹñÆâÀ½Â¤»ÜÀߤγÈÂç¤Ø500²¯¥É¥ëĶ¤òÅêÆþ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2025-3-17 7:00) |
¡¡ÊÆEli Lilly and Company¡Ê¥¤¡¼¥é¥¤¥ê¥ê¡¼¥¢¥ó¥É¥«¥ó¥Ñ¥Ë¡¼¡Ë¼Ò¤Ï2025ǯ2·î26Æü¡¢ÊƹñÆâ¤Ç¤Î¡¢¼£ÎÅÎΰèÁ´ÂΤˤ錄¤ë°åÌôÉÊÀ½Â¤¤ò¶¯²½¤¹¤ë·×²è¤ò¿Ê¤á¤Æ¤¤¤ë¤³¤È¤òÌÀ¤é¤«¤Ë¤·¤¿¡£Æ±Æü¡¢¥ï¥·¥ó¥È¥óD.C¤Ç³«ºÅ¤·¤¿µ¼Ô²ñ¸«¤Ç¡¢Æ±¼Ò¤ÎDavid A. Ricks CEO¤¬È¯É½¤·¤¿¡£
|
NIBIOHN¡¢À¸ÂÎ¥¤¥á¡¼¥¸¥ó¥°¤Î¼õÂ÷²òÀÏ¥×¥é¥Ã¥È¥Õ¥©¡¼¥à¤ò2025ǯ4·î¤Ë²ÔƯ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2025-3-17 7:00) |
¡¡°åÌô´ðÈס¦·ò¹¯¡¦±ÉÍܸ¦µæ½ê¡ÊNIBIOHN¡Ë¤Ï2025ǯ4·î¡¢ÁÏÌô¤òÌÜŪ¤Ë¡¢¥Ò¥È¤äưʪ¤ÎÁÈ¿¥¤òÀ¸¤¤¿¤Þ¤Þ¥ê¥¢¥ë¥¿¥¤¥à¤Ç´Ñ»¡¤Ç¤¤ëÀ¸ÂÎ¥¤¥á¡¼¥¸¥ó¥°¤Î¥×¥é¥Ã¥È¥Õ¥©¡¼¥à¡Ö¼¡À¤ÂåÀ¸ÂÎ¥¤¥á¡¼¥¸¥ó¥°ÁÏÌô¸¦µæ¥×¥é¥Ã¥È¥Õ¥©¡¼¥à¡×¤ò²ÔƯ¤µ¤»¡¢¼õÂ÷²òÀϤʤɤò³«»Ï¤¹¤ë¡£Æ±Ç¯3·î12Æü¡¢NIBIOHN¤ÏƱ¥×¥é¥Ã¥È¥Õ¥©¡¼¥à¤Ë´Ø¤¹¤ëÀâÌÀ²ñ¤ò³«¤¤¤¿¡£
|
ÊÆSummit¼Ò¤ÈPfizer¼Ò¡¢¸Ç·Á¤¬¤ó¤ËÆó½ÅÆðÛÀ¹³ÂΤÈADC¤òÊ»ÍѤ¹¤ëÎ×¾²»î¸³¤ò¶¦Æ±¼Â»Ü¤Ø from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2025-3-17 7:00) |
¡¡ÊÆSummit Therapeutics¡Ê¥µ¥ß¥Ã¥È¡¦¥»¥é¥Ô¥å¡¼¥Æ¥£¥¯¥¹¡Ë¼Ò¤Ï2025ǯ2·î24Æü¡¢PD-1¤ÈVEGF¤òɸŪ¤È¤·¤¿Æó½ÅÆðÛÀ¹³ÂΡʰìÈÌ̾¡§ivonescimab¡Ë¤òÊÆPfizer¡Ê¥Õ¥¡¥¤¥¶¡¼¡Ë¼Ò¤Î³×¿·Åª¤Ê¹³ÂÎÌôʪʣ¹çÂΡÊADC¡Ë¤ÈÁȤ߹ç¤ï¤»¡¢È󾮺Ù˦ÇÙ¤¬¤ó¤ä¤½¤Î¾¤ÎÊ£¿ô¼ïÎà¤Î¸Ç·Á¤¬¤ó¤Î´µ¼Ô¤ËŬÍѤ¹¤ëÎ×¾²»î¸³¤ò¶¦Æ±¤Ç¼Â»Ü¤¹¤ë¤¿¤á¤Î¶¨ÎÏ·ÀÌó¤ò·ë¤ó¤À¤Èȯɽ¤·¤¿¡£
|
2025ǯ3·î17Æü¹æ¡¡Ìܼ¡ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2025-3-17 6:59) |
|
¥Ñ¥¤¥×¥é¥¤¥ó¸¦µæ¡ýÂçIJ¤¬¤ó¼£ÎÅÌô¡Ú³«È¯Æ°¸þÊÔ¡Û¡¢ÂçIJ¤¬¤ó¼£ÎÅÌô¡¢KRASÁ˳²Ìô¤äVEGF¼õÍÆÂÎÁ˳²Ìô¤Ê¤É¼ÂÍÑ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2025-3-17 6:56) |
¡¡ÂçIJ¤ÏÌÕIJ¤«¤é·ëIJ¡Ê¾å¹Ô·ëIJ¡¢²£¹Ô·ëIJ¡¢²¼¹Ô·ëIJ¡¢S¾õ·ëIJ¡Ë¡¢Ä¾Ä²¡¢æêÌç´É¤Þ¤Ç¤ò»Ø¤¹¤¬¡¢¼ç¤Ë·ëIJ¤ÈľIJ¤Î¤¬¤ó¤òÂçIJ¤¬¤ó¤È¸Æ¤ó¤Ç¤¤¤ë¡£
|
4/2(¿å)Ë̳¤Æ»È¯¡§»¥ËÚ¥é¥ó¥Á²ñ¤Î¤´°ÆÆâ from ¤µ¤Ä¤²ñ¡ÁÅìÂç½÷»Ò¥Í¥Ã¥È¥ï¡¼¥¯¡¦¥³¥ß¥å¥Ë¥Æ¥£¡Á (2025-3-16 22:20) |
½Õ¤Îˬ¤ì¤ò´¶¤¸¤ëº£Æü¤³¤Îº¢¡¢Àã²ò¤±´Ö¶á¤Î»¥Ëڤǥé¥ó¥Á²ñ¤ò³«ºÅ¤·¤Þ¤¹¡£Ë̳¤Æ»ºß½»¤ÎÊý¤Ï¤â¤Á¤í¤ó¡¢¤¿¤Þ¤¿¤Þι¹Ô¤ä»Å»ö¤Ç»¥ËÚ¤ËÂںߤ·¤Æ¤¤¤ëÊý¤â¡¢¤¼¤Ò¤´»²²Ã¤¯¤À¤µ¤¤¡£Ã»»þ´Ö¤À¤±´é¤ò½Ð¤·¤¿¤¤¤È¤¤¤¦Êý¤âÂç´¿·Þ¤Ç¤¹¡£ÀʤΤßͽÌó¤·¡¢¤ª¿© […]
The post 4/2(¿å)Ë̳¤Æ»È¯¡§»¥ËÚ¥é¥ó¥Á²ñ¤Î¤´°ÆÆâ first appeared on ¤µ¤Ä¤²ñ¡ÁÅìÂç½÷»Ò¥Í¥Ã¥È¥ï¡¼¥¯¡¦¥³¥ß¥å¥Ë¥Æ¥£¡Á .
|
3/2(Æü)Âè5²óÅìÂç½÷»Ò¥Ð¥É¥ß¥ó¥È¥ó¸òή²ñ³«ºÅÊó¹ð from ¤µ¤Ä¤²ñ¡ÁÅìÂç½÷»Ò¥Í¥Ã¥È¥ï¡¼¥¯¡¦¥³¥ß¥å¥Ë¥Æ¥£¡Á (2025-3-16 21:36) |
5²óÌܤˤʤëÅìÂç½÷»Ò¥Ð¥É¥ß¥ó¥È¥ó¸òή²ñ¡£º£²ó¤Ï³ØÀ¸¤«¤é¤ÎÊó¹ð¤Ç¤¹¡£ »ä¤ÏÁ°²ó¤Ë°ú¤Â³¤2²óÌܤλ²²Ã¤Ç¡¢º£²ó¤Ïͧã¤òͶ¤Ã¤Æ»²²Ã¤·¤Þ¤·¤¿¡£Á´ÂΤÇ18¿Í½¸¤Þ¤ê¡¢³ØÀ¸¤¬È¾¿ô¤Û¤É¤Ç¤·¤¿¡£Ãæ¤Ë¤Ï¤¹¤Ã¤«¤ê¤ªÆëÀ÷¤ß¤Ë¤Ê¤Ã¤¿¥á¥ó¥Ð¡¼¤â¤¤¤Þ […]
The post 3/2(Æü)Âè5²óÅìÂç½÷»Ò¥Ð¥É¥ß¥ó¥È¥ó¸òή²ñ³«ºÅÊó¹ð first appeared on ¤µ¤Ä¤²ñ¡ÁÅìÂç½÷»Ò¥Í¥Ã¥È¥ï¡¼¥¯¡¦¥³¥ß¥å¥Ë¥Æ¥£¡Á .
|
¥Ð¥¤¥ª¥Ù¥ó¥Á¥ã¡¼³ô²Á½µÊó¡¢¥¯¥ª¥ê¥×¥¹¡¢Heartseed¡¢¥¹¥Æ¥à¥»¥ë¸¦¤¬¾å¾º¡¢¥ì¥Ê¥µ¥¤¥¨¥ó¥¹¡¢3D¥Þ¥È¥ê¥Ã¥¯¥¹¡ from Æü·Ð¥Ð¥¤¥ª¥Æ¥¯ONLINE (2025-3-14 19:30) |
¡¡ÆüËܤγô¼°»Ô¾ì¤Ë¾å¾ì¤¹¤ë¥Ð¥¤¥ª¥¹¥¿¡¼¥È¥¢¥Ã¥×¤Î³ô²Á¤ò½µ¤´¤È¤Ë¥¦¥©¥Ã¥Á¤·¤Æ¤¤¤¯¡Ö¥Ð¥¤¥ª¥Ù¥ó¥Á¥ã¡¼³ô²Á½µÊó¡×¡£2025ǯ3·î14Æü¤Î½ªÃͤ¬¡¢Á°½µ¤Î½µËö¡Ê3·î7Æü¡Ë¤Î½ªÃͤËÈæ¤Ù¤Æ¾å¾º¤·¤¿¤Î¤Ï43ÌÃÊÁ¡¢²¼Í¤¿¤Î¤Ï13ÌÃÊÁ¤À¤Ã¤¿¡£
|